Ident. | Authors (with country if any) | Title |
---|
000903 |
Hirofumi Emoto [Japon] ; Yukihisa Suzuki [Japon] ; Masato Wakakura [Japon] ; Chiharu Horie [Japon] ; Motohiro Kiyosawa [Japon] ; Manabu Mochizuki [Japon] ; Keiichi Kawasaki [Japon] ; Keiichi Oda [Japon] ; Kiichi Ishiwata [Japon] ; Kenji Ishii [Japon] | Photophobia in Essential Blepharospasm-A Positron Emission Tomographic Study |
001040 |
JI YOUN KIM [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; HEE YOUNG SHIN [Corée du Sud] ; GYEONG HAN LEE [Corée du Sud] ; Yearn-Seong Choe [Corée du Sud] ; Yong Choi [Corée du Sud] ; BYEONG JOON KIM [Corée du Sud] | Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease : Analysis of [11C] Raclopride PET Study |
001448 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; JI HYUN KO [Canada] ; Yu-Yan Poon [Canada] ; Elena Moro [Canada] | Subdural Motor Cortex Stimulation in Parkinson's Disease Does Not Modify Movement-Related rCBF Pattern |
001490 |
Thomas Eckert [États-Unis, Allemagne] ; Andrew Feigin [États-Unis] ; Daniel E. Lewis [États-Unis] ; Vijay Dhawan [États-Unis] ; Steven Frucht [États-Unis] ; David Eidelberg [États-Unis] | Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging |
001554 |
Daniela Perani [Italie] ; Valentina Garibotto [Italie] ; Andrea Panzacchi [Italie] ; Rosa Maria Moresco [Italie] ; Paola Ortelli [Italie] ; Massimo Corbo [Italie] ; Ferruccio Fazio [Italie] ; Franco Folli [États-Unis] | PET evidence of central GABAergic changes in stiff-person syndrome |
001570 |
Misuzu Saiki [Japon] ; Shinji Saiki [Japon] ; Koichiro Sakai [Japon] ; Ichiro Matsunari [Japon] ; Kotaro Higashi [Japon] ; Ken-Ya Murata [Japon] ; Nobutaka Hattori [Japon] ; Genjiro Hirose [Japon] | Neurological deficits are associated with increased brain calcinosis, hypoperfusion, and hypometabolism in idiopathic basal ganglia calcification |
001571 |
Anna L. Bartels [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] | Neuroinflammation in the pathophysiology of parkinson's disease : Evidence from animal models to human in vivo studies with [11C]-PK11195 PET |
001624 |
Steven A. Gunzler [États-Unis] ; A. Jon Stoessl [Canada] ; Robert A. Egan [États-Unis] ; Richard G. Weleber [États-Unis] ; Paul Wang [États-Unis] ; John G. Nutt [États-Unis] | Joubert syndrome surviving to adulthood associated with a progressive movement disorder |
001737 |
Kyum-Yil Kwon [Corée du Sud] ; Choong G. Choi [Corée du Sud] ; Jae S. Kim [Corée du Sud] ; Myoung C. Lee [Corée du Sud] ; Sun J. Chung [Corée du Sud] | Comparison of Brain MRI and 18F-FDG PET in the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease |
001819 |
Michael Behen [États-Unis] ; Harry T. Chugani [États-Unis] ; Csaba Juhasz [États-Unis] ; Emily Helder [États-Unis] ; Albert Ho [États-Unis] ; Mohsin Maqbool [États-Unis] ; Robert D. Rothermel [États-Unis] ; Jacquie Perry [États-Unis] ; Otto Muzik [États-Unis] | Abnormal Brain Tryptophan Metabolism and Clinical Correlates in Tourette Syndrome |
001892 |
Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas] | Striatal dopa and glucose metabolism in PD patients with freezing of gait |
001899 |
Matthias Reimold [Allemagne] ; Christoph Globas [Allemagne] ; Marc Gleichmann [Allemagne] ; Michael Schulze [Allemagne] ; Christian Gerloff [Allemagne] ; Roland Bares [Allemagne] ; H.-J. Machulla [Allemagne] ; Katrin Bürk [Allemagne] | Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome : Striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography |
001987 |
Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies |
001A55 |
Alexander Gerhard [Royaume-Uni] ; Iris Trender-Gerhard [Royaume-Uni] ; Federico Turkheimer [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy |
001B37 |
Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne] | Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration |
001C66 |
Brad A. Racette [États-Unis] ; Jo Ann Antenor [États-Unis] ; Lori Mcgee-Minnich [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Vikas Kotagal [États-Unis] ; Joel S. Perlmutter [États-Unis] | [18F]FDOPA PET and clinical features in parkinsonism due to manganism |
001D59 |
Naheed L. Khan [Royaume-Uni] ; Paola Giunti [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Michael O. Brien [Royaume-Uni] ; Paola Piccini [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6) |
001E78 |
Reinoud C. Klein [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] | Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease |
001F62 |
Atsuko Nagano-Saito [Japon] ; Yukihiko Washimi [Japon] ; Yutaka Arahata [Japon] ; Katsushige Iwai [Japon] ; Shoji Kawatsu [Japon] ; Kengo Ito [Japon] ; Akinori Nakamura [Japon] ; Yuji Abe [Japon] ; Takako Yamada [Japon] ; Takashi Kato [Japon] ; Teruhiko Kachi [Japon] | Visual hallucination in Parkinson's disease with FDG PET |
002071 |
Alan L. Whone [Royaume-Uni] ; Sarah Von Spiczak [Royaume-Uni] ; Mark Edwards [Royaume-Uni] ; Enza-Maria Valente [Royaume-Uni] ; Alexander Hammers [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Opioid binding in DYT1 primary torsion dystonia: An 11C-diprenorphine PET study |
002129 |
Alexander Gerhard [Royaume-Uni] ; Justin Watts [Royaume-Uni, États-Unis] ; Iris Trender-Gerhard [Royaume-Uni] ; Federico Turkheimer [Royaume-Uni] ; Richard B. Banati [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration |
002136 |
K. Henkel [Allemagne] ; J. Karitzky [Allemagne] ; M. Schmid [Allemagne] ; I. Mader [Allemagne] ; G. Glatting [Allemagne] ; J. W. Unger [Allemagne] ; B. Neumaier [Allemagne] ; A. C. Ludolph [Allemagne] ; S. N. Reske [Allemagne] ; G. B. Landwehrmeyer [Allemagne] | Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration |
002213 |
L. Vela [États-Unis] ; G. N. Sfakianakis [États-Unis] ; D. Heros [États-Unis] ; W. Koller [États-Unis] ; C. Singer [États-Unis] | Chorea and contraceptives: Case report with PET study and review of the literature |
002279 |
David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Use of functional imaging in parkinsonism and dementia |
002325 |
Kirn R. Kessler [Allemagne] ; Gilbert Wunderlich [Allemagne] ; Harald Hefter [Allemagne] ; Rüdiger J. Seitz [Allemagne] | Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density |
002422 |
David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis] | Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease |
002544 |
Carla Battisti [Italie] ; Patrizla Tarugi [Italie] ; Maria Teresa Dotti [Italie] ; Nicola De Stefano [Italie] ; Angelo Vattimo [Italie] ; Francesea Chierichetti [Italie] ; Sebastiano Calandra [Italie] ; Antonio Federico [Italie] | Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study |
002646 |
Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Jan Booij [Pays-Bas] ; Jaap Valk [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Martin Horstink [Pays-Bas] | Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway |
002716 |
Paul Morrish [Royaume-Uni] | Is it time to abandon functional imaging in the study of neuroprotection? |
002862 |
Michele T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Jozef Jarosz [Royaume-Uni] ; Lidia Yaguez [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | An imaging study of parkinsonism among African-Caribbean and Indian London communities |
002877 |
Jorge Iriarte [Espagne] ; Manuel Alegre [Espagne] ; Javier Arbizu [Espagne] ; Purificacion De Castro [Espagne] | Unilateral Periodic limb movements during sleep in corticobasal degeneration |
002915 |
Georg Berding [Allemagne] ; Per Odin [Allemagne] ; David J. Brooks [Royaume-Uni] ; Guido Nikkhah [Allemagne] ; Cordula Matthies [Allemagne] ; Thomas Peschel [Allemagne] ; Mona Shing [Allemagne] ; Hans Kolbe [Allemagne] ; Jörg Van Den Hoff [Allemagne] ; Harald Fricke [Allemagne] ; Reinhard Dengler [Allemagne] ; Madjid Samii [Allemagne] ; Wolfram H. Knapp [Allemagne] | Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the Off and On conditions with [18F]FDG-PET |
002918 |
Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande] | Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study |
002A25 |
N. J. Cordato [Australie] ; G. M. Halliday [Australie] ; L. Davies [Australie] ; P. Williamson [Australie] ; M. Fulham [Australie] ; J. G. L. Morris [Australie] | Corticobasal syndrome with tau pathology |
002A43 |
Pierre-Francois Pradat [France] ; Corinne Dupel-Pottier [France] ; Lucette Lacomblez [France] ; Francois Salachas [France] ; Vincent Meininger [France] ; Laurent Spelle [France] ; Isabelle Bonnaud [France] ; Marie Joao Ribeiro [France] ; Philippe Remy [France] ; Yves Samson [France] | Case record of pallido-pyramidal disease with supplementary motor area involvement |
002A79 |
Gaetan Garraux [Belgique] ; Eric Salmon [Belgique] ; Philippe Peigneux [Belgique] ; Alexandre Kreisler [France] ; Christian Degueldre [Belgique] ; Christian Lemaire [Belgique] ; Alain Destée [France] ; Georges Franck [Belgique] | Voxel-based distribution of metabolic impairment in corticobasal degeneration |
002B53 |
Laurent Vercueil [France] ; Abdallah Hammouti [France] ; Marcellin L. Andriantseheno [France] ; Michel Mohr [France] ; Christine Tranchant [France] ; Pierre Maquet [Belgique] ; Christian Marescaux [France] ; Francois Sellal [France] | Pallido-luysio-nigral atrophy revealed by rapidly progressive hemidystonia : A clinical, radiologic, functional, and neuropathologic study |
002D13 |
C. Dentresangle [France] ; L. Veyre [France] ; D. Le Bars [France] ; C. Pierre [France] ; F. Lavenne [France] ; Pierre Pollak [France] ; J. Guerin [France] ; J.-C. Froment [France] ; E. Brousolle [France] | Striatal D2 dopamine receptor status in Parkinson's disease : An [18F]dopa and [11C]raclopride PET study |
002D46 |
C. Trenkwalder [Allemagne] ; A. S. Walters [États-Unis] ; W. A. Hening [États-Unis] ; S. Chokroverty [États-Unis] ; A. Antonini [États-Unis] ; V. Dhawan [États-Unis] ; D. Eidelberg [États-Unis] | Positron emission tomographic studies in restless legs syndrome |
002D68 |
A. Brashear [États-Unis] ; G. K. Mulholland [États-Unis] ; Q.-H. Zheng [États-Unis] ; M. R. Farlow [États-Unis] ; E. R. Siemers [États-Unis] ; G. D. Hutchins [États-Unis] | PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP) |
002E98 |
O. Lindvall [Suède] | Update on fetal transplantation : The Swedish experience |
002F29 |
J. Sunden-Cullberg [Suède] ; J. Tedroff [Suède] ; S.-M. Aquilonius [Suède] | Reversible chorea in primary antiphospholipid syndrome |
002F40 |
D. J. Cordato [Australie] ; M. J. Fulham [Australie] ; C. Yiannikas [Australie] | Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease |
002F93 |
E. D. Playford [Royaume-Uni] ; R. E. Passingham [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Increased activation of frontal areas during arm movement in idiopathic torsion dystonia |
003014 |
H. Boecker [Royaume-Uni, Allemagne] ; D. J. Brooks [Royaume-Uni] | Functional imaging of tremor |
003031 |
R. Mielke [Allemagne] ; R. Hilker [Allemagne] ; G. Weber-Luxenburger [Allemagne] ; J. Kessler [Allemagne] ; W.-D. Heiss [Allemagne] | Early-onset cerebellar ataxia (EOCA) with retained reflexes : Reduced cerebellar benzodiazepine-receptor binding, progressive metabolic and cognitive impairment |
003039 |
A. Antonini [États-Unis] ; K. Kazumata [États-Unis] ; A. Feigin [États-Unis] ; F. Mandel [États-Unis] ; V. Dhawan [États-Unis] ; C. Margouleff [États-Unis] ; D. Eidelberg [États-Unis] | Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET |
003068 |
M. Tanaka [Japon] ; S. Hirai [Japon] ; S. Kondo [Japon] ; X. Sun [Japon] ; T. Nakagawa [Japon] ; S. Tanaka [Japon] ; K. Hayashi [Japon] ; K. Okamoto [Japon] | Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis : A combined PET and MRI study |
003069 |
T. Odergren [Suède] ; S. Stone-Elander [Suède] ; M. Ingvar [Suède] | Cerebral and cerebellar activation in correlation to the action-induced dystonia in Writer's cramp |
003075 |
S. Dethy [Belgique] ; N. Van Blercom [Belgique] ; P. Damhaut [Belgique] ; D. Wikler [Belgique] ; J. Hildebrand [Belgique] ; S. Goldman [Belgique] | Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism |
003076 |
C. Singer [États-Unis] ; N. J. Schatz [États-Unis] ; B. Bowen [États-Unis] ; D. Eidelberg [États-Unis] ; K. Kazumata [États-Unis] ; L. Sternau [États-Unis] ; L. M. Shulman [États-Unis] ; W. J. Weiner [États-Unis] | Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst |
003107 |
M. Naumann [Allemagne] ; W. Pirker [Autriche] ; K. Reiners [Allemagne] ; K. Lange [Allemagne] ; G. Becker [Allemagne] ; T. Brücke [Autriche] | [123I]β-CIT single-photon emission tomography in DOPA-responsive dystonia |
003203 |
A. Antonini [Suisse] ; J. Schwarz [Suisse] ; W. H. Oertel [Suisse] ; O. Pogarell [Suisse] ; K. L. Leenders [Suisse, Allemagne] | Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride |
003266 |
S. Magyar-Lehmann [Suisse] ; A. Antonini [Suisse] ; U. Roelcke [Suisse] ; R. P. Maguire [Suisse] ; J. Missimer [Suisse] ; M. Meyer [Suisse] ; K. L. Leenders [Suisse] | Cerebral glucose metabolism in patients with spasmodic torticollis |
003427 |
G. Pezzoli [Italie] ; A. Antonini ; S. Barbieri [Italie] ; M. Canesi [Italie] ; L. Perbellini ; A. Zecchinelli [Italie] ; C. B. Mariani [Italie] ; A. Bonetti [Italie] ; K. L. Leenders | n-Hexane-induced Parkinsonism : pathogenetic hypotheses |
003428 |
E. R. P. Brunt [Pays-Bas] ; T. W. Van Weerden ; J. Pruim ; J. W. P. F. Lakke [Pays-Bas] | Unique myoclonic pattern in corticobasal degeneration |
003470 |
K. Westermark [Suède] ; J. Tedroff ; K.-A. Thuomas ; P. Hartvig ; B. Langström ; Y. Andersson ; K. Hörnfeldt ; S.-M. Aquilonius | Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers |
003482 |
D. Smith [États-Unis] ; T. Ishikawa ; V. Dhawan ; J. S. Winterkorn ; D. Eidelberg [États-Unis] | Lid opening apraxia is associated with medial frontal hypometabolism |
003485 |
J. Opacka-Juffry [Royaume-Uni] ; D. J. Brooks | L-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory roles |
003535 |
C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. Garnett | A probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain |
003670 |
G. V. Sawle [Royaume-Uni] | The detection of preclinical Parkinson's disease: what is the role of positron emission tomography? |
003684 |
S. Goldman [Belgique] ; D. Amrom ; H. B. Szliwowski ; D. Detemmerman ; S. Goldman ; L. M. Bidaut [Belgique] ; E. Stanus [Belgique] ; A. Luxen [Belgique] | Reversible striatal hypermetabolism in a case of Sydenham's chorea |
003703 |
J. O. Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. Nagren ; J. Bergman ; U. Ruotsalainen | PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease |
003740 |
T. Kuwert [Allemagne] ; J. Noth ; D. Scholz [Allemagne] ; M. Schwarz ; H. W. Lange ; R. Töpper ; H. Herzog [Allemagne] ; A. Aulich ; L. E. Feinendegen [Allemagne] | Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease |
003826 |
J. Blin [France] ; M.-J. Vidailhet [France] ; B. Pillon [France] ; B. Dubois [France] ; J.-R. Feve [France] ; Yves Agid [France] | Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET |